IN2012MN02218A - - Google Patents
Info
- Publication number
- IN2012MN02218A IN2012MN02218A IN2218MUN2012A IN2012MN02218A IN 2012MN02218 A IN2012MN02218 A IN 2012MN02218A IN 2218MUN2012 A IN2218MUN2012 A IN 2218MUN2012A IN 2012MN02218 A IN2012MN02218 A IN 2012MN02218A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Birds (AREA)
- Virology (AREA)
- Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30699110P | 2010-02-23 | 2010-02-23 | |
| PCT/IL2011/000181 WO2011104707A1 (en) | 2010-02-23 | 2011-02-23 | Methods and compositions for enhancing fat graft survival |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012MN02218A true IN2012MN02218A (https=) | 2015-06-12 |
Family
ID=44506187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2218MUN2012 IN2012MN02218A (https=) | 2010-02-23 | 2012-09-20 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20120315254A1 (https=) |
| EP (1) | EP2539443B1 (https=) |
| JP (2) | JP5823986B2 (https=) |
| CN (1) | CN102906250A (https=) |
| AU (1) | AU2011219425A1 (https=) |
| BR (1) | BR112012021179A2 (https=) |
| CA (1) | CA2790867A1 (https=) |
| IL (1) | IL221619A (https=) |
| IN (1) | IN2012MN02218A (https=) |
| MX (1) | MX2012009768A (https=) |
| RU (1) | RU2012140379A (https=) |
| WO (1) | WO2011104707A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012021179A2 (pt) * | 2010-02-23 | 2015-09-15 | Sebana Medical Ltd | método para aprimorar a sobrevivência da gordura adiposa em um paciente que necessite da mesma, uso de eritropoietina e composição farmacêutica |
| JP5953035B2 (ja) * | 2011-11-28 | 2016-07-13 | 学校法人慶應義塾 | 病理診断支援装置、病理診断支援方法、及び病理診断支援プログラム |
| CN107456606A (zh) * | 2017-08-30 | 2017-12-12 | 上海新肌生物科技有限公司 | 一种脂肪细胞存活率提高91%的复活素配方及制备方法 |
| CN110229785A (zh) * | 2019-06-17 | 2019-09-13 | 白晋 | 一种利用血管内皮祖细胞提升脂肪移植成功率的方法 |
| CN111548988B (zh) * | 2020-05-14 | 2023-06-20 | 江苏芝海生物科技有限公司 | 一种医用漂洗液及其制备方法和应用 |
| CA3200227A1 (en) * | 2020-11-25 | 2022-06-02 | Alexandra Sophie DE BOER | Adipogenic cell compositions and methods |
| CN113413177B (zh) * | 2021-06-23 | 2022-08-02 | 美闺(长沙)医疗美容有限公司 | 一种保持自体脂肪活性的移植设备及控制方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7651684B2 (en) * | 2001-12-07 | 2010-01-26 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| US20050048035A1 (en) | 2001-12-07 | 2005-03-03 | Fraser John K. | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| US7459152B2 (en) * | 2003-04-23 | 2008-12-02 | Rush University Medical Center | Erythropoietin administration to improve graft survival |
| AU2004260638A1 (en) * | 2003-06-18 | 2005-02-10 | Macropore Biosurgery Inc. | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| AU2004309083B2 (en) * | 2003-12-30 | 2010-11-11 | Augustinus Bader | Tissue regeneration method |
| ITPD20050168A1 (it) * | 2005-06-01 | 2006-12-02 | Fidia Advanced Biopolymers Srl | Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico |
| WO2007087402A2 (en) * | 2006-01-24 | 2007-08-02 | Brown University | Cell aggregation and encapsulation device and method |
| WO2008019434A1 (en) | 2006-08-14 | 2008-02-21 | Victorian Tissue Engineering Pty Ltd | The use of growth factors in a method of improving fat-graft survival |
| JP5869219B2 (ja) * | 2007-08-16 | 2016-02-24 | レメドー バイオメッド リミテッド | 治療および美容適用のためのエリスロポイエチンおよびフィブロネクチン組成物 |
| BR112012021179A2 (pt) * | 2010-02-23 | 2015-09-15 | Sebana Medical Ltd | método para aprimorar a sobrevivência da gordura adiposa em um paciente que necessite da mesma, uso de eritropoietina e composição farmacêutica |
-
2011
- 2011-02-23 BR BR112012021179A patent/BR112012021179A2/pt not_active IP Right Cessation
- 2011-02-23 MX MX2012009768A patent/MX2012009768A/es not_active Application Discontinuation
- 2011-02-23 CA CA2790867A patent/CA2790867A1/en not_active Abandoned
- 2011-02-23 CN CN2011800205877A patent/CN102906250A/zh active Pending
- 2011-02-23 WO PCT/IL2011/000181 patent/WO2011104707A1/en not_active Ceased
- 2011-02-23 AU AU2011219425A patent/AU2011219425A1/en not_active Abandoned
- 2011-02-23 EP EP11746961.9A patent/EP2539443B1/en active Active
- 2011-02-23 US US13/580,381 patent/US20120315254A1/en active Pending
- 2011-02-23 JP JP2012554466A patent/JP5823986B2/ja active Active
- 2011-02-23 RU RU2012140379/15A patent/RU2012140379A/ru unknown
-
2012
- 2012-08-23 IL IL221619A patent/IL221619A/en active IP Right Grant
- 2012-09-20 IN IN2218MUN2012 patent/IN2012MN02218A/en unknown
-
2015
- 2015-10-08 JP JP2015200614A patent/JP6023864B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| IL221619A (en) | 2017-09-28 |
| JP5823986B2 (ja) | 2015-11-25 |
| RU2012140379A (ru) | 2014-03-27 |
| JP6023864B2 (ja) | 2016-11-09 |
| EP2539443A1 (en) | 2013-01-02 |
| CN102906250A (zh) | 2013-01-30 |
| MX2012009768A (es) | 2013-02-27 |
| AU2011219425A1 (en) | 2012-10-18 |
| BR112012021179A2 (pt) | 2015-09-15 |
| JP2016041261A (ja) | 2016-03-31 |
| JP2013520271A (ja) | 2013-06-06 |
| EP2539443B1 (en) | 2019-03-27 |
| US20120315254A1 (en) | 2012-12-13 |
| CA2790867A1 (en) | 2011-09-01 |
| EP2539443A4 (en) | 2013-12-11 |
| WO2011104707A1 (en) | 2011-09-01 |